2-bromopalmitate has been researched along with Disease Models, Animal in 4 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, SS; Hu, W; Ko, BC; Li, Z; Liao, C; Lu, XP; Ning, ZQ; Pan, D; Shan, S; Shi, L; Tong, EH; Wong, VK; Yin, Z; Zhou, J | 1 |
| Cheng, M; Jiao, M; Wang, B; Xie, M; Yu, L; Zhu, H | 1 |
| Eitnier, RA; Haines, RJ; Wang, CY; Wang, F; Wu, MH; Yang, CGY | 1 |
| Atzori, M; Bermeo, J; D'Mello, S; Farmer, GE; Galindo, LC; Garcia-Oscos, F; Hall, S; Ramirez, RD; Rose-John, S; Salgado, H; Thomas, F | 1 |
4 other study(ies) available for 2-bromopalmitate and Disease Models, Animal
| Article | Year |
|---|---|
Design, synthesis, and evaluation of a new class of noncyclic 1,3-dicarbonyl compounds as PPARalpha selective activators.
Topics: Adipose Tissue; Administration, Oral; Aldehydes; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Design; Hypolipidemic Agents; Ketones; Lipid Metabolism; Mice; PPAR alpha; PPAR delta; PPAR gamma; Structure-Activity Relationship | 2004 |
2-Bromopalmitate attenuates inflammatory pain by maintaining mitochondrial fission/fusion balance and function.
Topics: Animals; Anti-Inflammatory Agents; Astrocytes; bcl-2-Associated X Protein; Behavior, Animal; Cell Line, Tumor; Disease Models, Animal; Dynamins; Freund's Adjuvant; Glial Fibrillary Acidic Protein; GTP Phosphohydrolases; Humans; Inflammation; Interleukin-1beta; Matrix Metalloproteinases; Membrane Potential, Mitochondrial; Mitochondrial Dynamics; Oxidative Stress; Pain; Palmitates; Rats, Sprague-Dawley; Reactive Oxygen Species; Spinal Cord; Tumor Necrosis Factor-alpha | 2021 |
Targeting palmitoyl acyltransferase ZDHHC21 improves gut epithelial barrier dysfunction resulting from burn-induced systemic inflammation.
Topics: Acyltransferases; Animals; Burns; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Epithelial Cells; Genotype; Inflammation; Interferon-gamma; Intestinal Mucosa; Jejunum; Lipoylation; Male; Mice, Inbred C57BL; Mice, Knockout; Palmitates; Permeability; Phenotype; Time Factors; Tumor Necrosis Factor-alpha | 2017 |
The stress-induced cytokine interleukin-6 decreases the inhibition/excitation ratio in the rat temporal cortex via trans-signaling.
Topics: Androstadienes; Animals; Brefeldin A; Cytokine Receptor gp130; Disease Models, Animal; Drug Interactions; Electric Stimulation; Excitatory Postsynaptic Potentials; Inhibitory Postsynaptic Potentials; Interleukin-6; Lipopolysaccharides; Muscimol; Oligopeptides; Palmitates; Rats; Stress, Psychological; Temporal Lobe; Wortmannin | 2012 |